Pharming (PHAR) Cash from Operations (2020 - 2025)
Pharming (PHAR) posted Cash from Operations of 10707000.0 for Q4 2025, up 696.49% on a QoQ basis from 1795000.0 in Q4 2024, and up 696.49% year-over-year from 1344272.57 in Q4 2024.
Pharming (PHAR) Cash from Operations (2020 - 2025) Analysis & Trends
Pharming's Cash from Operations history runs 6 years deep, the most recent figure standing at 10707000.0 for Q4 2025.
- Quarterly Cash from Operations rose 696.49% year-over-year to 10707000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1352000.0 (up 123.2% YoY) and the FY2025 annual result came in at 54708000.0, up 3147.8% from the prior year.
- Cash from Operations was 10707000.0 for Q4 2025 at Pharming, up from 1795000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 12616000.0 in Q3 2022 and bottomed at 32406000.0 in Q2 2023.
- A 5-year average of 173254.89 and a median of 4517725.54 in 2021 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2021 — Cash from Operations soared 7991.57% — and 2023, when it sank 2941.05%.
- Pharming's Cash from Operations stood at 7061000.0 in 2021, then plunged by 91.38% to 609000.0 in 2022, then sank by 2941.05% to 17302000.0 in 2023, then jumped by 89.63% to 1795000.0 in 2024, then surged by 696.49% to 10707000.0 in 2025.
- Business Quant data shows PHAR's Cash from Operations at 10707000.0 in Q4 2025, 1795000.0 in Q4 2024, and 9742000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 201.34 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -354.17 Mn |
| 10 | Pharming | 8.69 Bn | 8.64 Bn | 65.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.71 Mn |
| Dec 31, 2025 | 10.71 Mn |
| Dec 31, 2024 | -1.80 Mn |
| Dec 31, 2024 | -1.80 Mn |
| Sep 30, 2024 | 9.74 Mn |
| Sep 30, 2024 | 9.74 Mn |
| Dec 31, 2023 | -17.30 Mn |
| Dec 31, 2023 | -17.30 Mn |
| Sep 30, 2023 | 3.53 Mn |
| Sep 30, 2023 | 3.53 Mn |
| Jun 30, 2023 | -32.41 Mn |
| Jun 30, 2023 | -32.41 Mn |
| Dec 31, 2022 | 609,000.00 |
| Dec 31, 2022 | 609,000.00 |
| Sep 30, 2022 | 12.62 Mn |
| Sep 30, 2022 | 12.62 Mn |
| Dec 31, 2021 | 7.06 Mn |
| Dec 31, 2021 | 7.06 Mn |
| Sep 30, 2021 | 5.51 Mn |
| Sep 30, 2021 | 5.51 Mn |